Lysosomal Disease Summit 2026 Convenes Global Experts in Melbourne This October
Programme Development and Abstract Submissions Underway for October 2026 Meeting
Melbourne, Australia | 20 March 2026 – The Lysosomal Disease Summit will take place 2–3 October 2026 at Rydges Melbourne, bringing together clinicians, researchers, and industry leaders from around the world to advance lysosomal disease research and patient care.
Building on strong international engagement in previous years, the Summit continues to expand its global reach, with early interest from stakeholders across multiple regions. Abstract submissions and programme development are now underway, reflecting sustained momentum and growing collaboration across the lysosomal disease community.
Designed for clinicians, researchers, policy makers, and health system stakeholders, the 2026 Summit will provide a platform to share emerging evidence, explore evolving therapeutic approaches, and foster meaningful cross-disciplinary exchange.
“Innovation in lysosomal disease continues to accelerate through global collaboration,” said Professor Maria Fuller, BAppSc, MAppSc, PhD, FFSc (RCPA), Course Director. “The Summit brings together diverse perspectives to support scientific progress and improve patient outcomes worldwide.”
Programme Highlights
- Scientific presentations from international and APAC-based experts
- Panel discussions addressing current challenges and future directions
- Sessions focused on diagnostics, therapeutics, and patient care models
- Opportunities for collaboration across clinical, research, and industry communities
Attendees will engage with leading voices in lysosomal disease research and treatment, gaining insight into the latest developments shaping the field and contributing to ongoing advancements in care.
Registration details and additional programme information will be announced soon.
About the Lysosomal Disease Summit
The Lysosomal Disease Summit is a collaborative effort with Fabry Australia and independently managed by Etherio. It is a premier scientific event dedicated to advancing research, collaboration, and innovation in the treatment and care of lysosomal diseases. The Summit serves as a vital forum for experts across the APAC region and beyond to share knowledge and drive progress in the field.